Critical Contrast: Aimei Health Technology (AFJK) & The Competition

Aimei Health Technology (NASDAQ:AFJK) is one of 89 publicly-traded companies in the “UNCLASSIFIED” industry, but how does it contrast to its peers? We will compare Aimei Health Technology to related businesses based on the strength of its earnings, analyst recommendations, valuation, risk, profitability, institutional ownership and dividends.

Profitability

This table compares Aimei Health Technology and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Aimei Health Technology	N/A	-95.88%	3.06%
Aimei Health Technology Competitors	0.86%	0.95%	0.80%

Analyst Ratings

This is a breakdown of current ratings for Aimei Health Technology and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aimei Health Technology	1	0	0	0	1.00
Aimei Health Technology Competitors	206	262	217	3	2.02

As a group, “UNCLASSIFIED” companies have a potential upside of 65.42%. Given Aimei Health Technology’s peers stronger consensus rating and higher probable upside, analysts clearly believe Aimei Health Technology has less favorable growth aspects than its peers.

Institutional and Insider Ownership

45.6% of Aimei Health Technology shares are held by institutional investors. Comparatively, 52.0% of shares of all “UNCLASSIFIED” companies are held by institutional investors. 2.5% of Aimei Health Technology shares are held by insiders. Comparatively, 42.4% of shares of all “UNCLASSIFIED” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Volatility and Risk

Aimei Health Technology has a beta of -0.03, meaning that its stock price is 103% less volatile than the S&P 500. Comparatively, Aimei Health Technology’s peers have a beta of -0.11, meaning that their average stock price is 111% less volatile than the S&P 500.

Earnings & Valuation

This table compares Aimei Health Technology and its peers revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Aimei Health Technology	N/A	$2.55 million	49.87
Aimei Health Technology Competitors	$47.83 million	-$19.62 million	94.60

Aimei Health Technology’s peers have higher revenue, but lower earnings than Aimei Health Technology. Aimei Health Technology is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Summary

Aimei Health Technology peers beat Aimei Health Technology on 10 of the 13 factors compared.

Aimei Health Technology Company Profile

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.